急性髓性白血病的当代管理:一篇评论
Sangeetha Venugopal1, Mikkael A Sekeres1
1Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida.
急性髓性白血病 (AML) 治疗正在通过向疗法和基因组分析而发展. 新的方法改善了AML患者的治疗结果,尤其是老年人.
科学领域:
- 血液瘤学 血液瘤学
- 基因组医学是基因组医学.
- 癌症治疗方法 癌症治疗方法
背景情况:
- 急性髓性白血病 (AML) 是一种异质癌症,影响正常的血细胞发育.
- 随着年龄的增长,AML的发病率会增加,这带来了严重的死亡风险.
- 了解AML的遗传复杂性对于有效治疗至关重要.
研究的目的:
- 审查目前针对AML的前线治疗方法.
- 讨论指导AML治疗策略的原则.
- 为突出AML分子向治疗的进展.
主要方法:
- 审查支持当前AML治疗的证据.
- 分析主要治疗指导原则.
- 检查分子向AML治疗的进展情况.
主要成果:
- 在AML中常见的改变基因包括FLT3,NPM1,DNMT3A,IDH1/2,TET2,RUNX1,NRAS和TP53.
- 自2010年以来,分子数据集成已经完善了AML的预后和治疗.
- 有针对性的疗法 (例如,midostaurin,gilteritinib,ivosidenib) 和组合疗法 (例如,低甲基化剂+venetoclax) 改善了治疗结果.
结论:
- 基于患者的并发病和基因组资料,AML治疗越来越个性化.
- 分子向疗法和新组合正在彻底改变AML管理.
- 造血细胞移植现在在AML治疗中得到了更合理的应用.
更多相关视频
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
06:33Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
Published on: November 10, 2023
相关概念视频
Differentiation of Common Myeloid Progenitor Cells
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Regulation of Hematopoietic Stem Cells
